Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Oct 04, 2020 4:30pm
53 Views
Post# 31664758

RE:RE:RE:RE:RE:RE:RE:Blast ... Part 2

RE:RE:RE:RE:RE:RE:RE:Blast ... Part 2Mugsy, you keep singing about PLD and the great MNGT. Can you show at which time did Paladin share value dropped 40% from t's high? We want to know and compare. Do not get off topics as you usually do on. purpose. Simply answer the question if you can. if you do not it will simply mean that PLD never lost 40% value from its high. GUD mngt currently have been a complete failure. There is reason why they stay silent as they know well that they have failed investors and badly. Buying GBT not was adventurism. If it was not why are they not talking about GBT potentials. Oh…yes they like to talk about the past of PDL.
This time around they cannot blame Meir to get voted again in. Tick .... tock May 2021 will come soon....... and out they good ridden no new MNGT cab so bad as this one and with a billion dollar in their hands.  Oh yes, they have more money. Are they looking for another GBT?  Hard to find a bad deal?
Next time investors will vote with their pockets 
Bullboard Posts